Macula displacement common after RRD repair

Article

Macula displacement is common after rhematogenous retinal detachment (RRD) repair and is heterogenous in nature, reveals a recent study.

Macula displacement is common after rhematogenous retinal detachment (RRD) repair and is heterogenous in nature, reveals a recent study.

A team headed by Dr Edward Lee, Department of Ophthalmology, St Thomas’ Hospital, London, UK, postoperatively investigated patients undergoing primary RRD repair using fundus autofluorescence and OCT imaging. The results were assessed for correlations with symptoms and preoperative features.

In 72% of 32 consecutive fovea-involving detachments treated with vitrectomy and gas macula displacement was evident. This was also seen in 29.4% of foveal-sparing cases treated with vitrectomy and gas and in all patients with fovea-involving cases with detachments treated by vitrectomy and oil.

The results revealed a significant correlation between the presence of macula displacement and symptoms of distortion in the early postoperative period. Patients with symptoms described bending of lines with or without objects appearing as smaller or narrower in the operated eye. The extent of displacement was linked with distance from the optic disc and the extent of retinal detachment.

The group discovered that most affected patient, who underwent RRD repair, are symptomatic in the early postoperative period.

The abstract can be found in the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.